Dr. Reddy’s has been denied permission to undertake phase 3 trials of Russia’s Sputnik Light vaccine in India, according to a report.
According to ANI, Dr. Reddy’s has been denied permission to perform phase 3 trials for the Sputnik Light vaccine in India. According to the article, the Indian drug regulatory agency has denied authorization to perform phase 3 trials of the Russian Covid-19 vaccine in the country, citing sources.
More information is awaited.
Indian drug regulatory body has denied permission to Dr Reddy’s to conduct phase 3 trials for Sputnik light in India: Sources#COVID19 pic.twitter.com/7O5vgiHL8D
— ANI (@ANI) July 1, 2021
Sputnik Light, a single-dose vaccination during trials on Russians, was found to be 79.4% effective against the coronavirus.
Dr. Reddy’s, a Hyderabad-based pharmaceutical business, announced earlier on Tuesday (June 29, 2021) that the commercial launch of Sputnik V is likely to be delayed due to reliance on imported consignments and quality testing.
Dr. Reddy’s has stated that it intends to expand the soft launch to 28 cities by the end of the trial period.
“The limited pilot soft launch of the Sputnik V vaccine in India has now been successfully scaled up to other cities such as Visakhapatnam, Bengaluru, Mumbai, Kolkata, Delhi, Baddi, Chennai, Miryalaguda, and Kolhapur, with more cities to follow in the coming days,” the Hyderabad-based pharmaceutical company tweeted on June 16.
On April 12, 2021, India authorised Sputnik V and granted it emergency usage authorization.
